Implantable devices
Search documents
Globus Medical’s (NYSE:GMED) Q3: Strong Sales, Stock Jumps 19.2%
Yahoo Finance· 2025-11-06 22:08
We can dig further into the company’s sales dynamics by analyzing its constant currency revenue, which excludes currency movements that are outside their control and not indicative of demand. Over the last two years, its constant currency sales averaged 58.8% year-on-year growth. Because this number is better than its normal revenue growth, we can see that foreign exchange rates have been a headwind for Globus Medical.We at StockStory place the most emphasis on long-term growth, but within healthcare, a hal ...